Skip to main content

Table 2 Characteristics of patients with or without observed initiation of BOT (categorical variables)

From: Treatment intensification using long-acting insulin –predictors of future basal insulin supported oral therapy in the DIVE registry

Covariate

Total population

BOT(observed)

BOT(not observed)

p-value

(N = 31,008)

(N = 6,705)

(N = 24,303)

n (%)

n (%)

n (%)

Gender

    

 Male

16,728 (53.9)

3,698 (55.2)

13,030 (53.6)

0.026

 Female

14,280 (46.1)

3,007 (44.8)

11,273 (46.4)

Microvascular diseasesa

    

 Yes

10,851 (35.0)

2,643 (39.4)

8,208 (33.8)

<0.0001

 No

20,157 (65.0)

4,062 (60.6)

16,095 (66.2)

Macrovascular diseases

    

 Yes

7,377 (23.8)

1,711 (25.5)

5,666 (23.3)

<0.001

 No

23,631 (76.2)

4,994 (74.5)

18,637 (76.7)

Hypoglycaemia

    

 Yes

86 (0.3)

36 (0.5)

50 (0.2)

<0.0001

 No

30,922 (99.7)

6,669 (99.5)

24,253 (99.8)

  1. Legend: BOT basal supported oral therapy. Test for independence between groups by means of Fisher’s exact tests
  2. aPatient and/or physician reported data